MeSH term
Frequency | Condition_Probility | Animals | 38 | 0.0 |
Humans | 81 | 0.0 |
Amino Acid Sequence | 25 | 0.0 |
*CDC2-CDC28 Kinases | 11 | 1.0 |
Cyclin-Dependent Kinases/*physiology | 4 | 8.0 |
HIV-1/*genetics | 2 | 0.0 |
Hela Cells | 20 | 0.0 |
Molecular Sequence Data | 30 | 0.0 |
Phosphorylation | 28 | 0.0 |
*Promoter Regions (Genetics) | 3 | 0.0 |
Protein-Serine-Threonine Kinases/*physiology | 5 | 4.0 |
Research Support, Non-U.S. Gov't | 72 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 27 | 0.0 |
*Transcription, Genetic | 7 | 0.0 |
Cell Line | 7 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Glutathione Transferase/metabolism | 3 | 0.0 |
Kinetics | 3 | 0.0 |
Mutagenesis, Site-Directed | 4 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Protein Binding | 6 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/*metabolism | 6 | 2.0 |
Recombinant Fusion Proteins/metabolism | 3 | 0.0 |
Xenopus laevis | 2 | 0.0 |
*Cell Cycle Proteins | 5 | 0.0 |
Cyclin-Dependent Kinases/*metabolism | 11 | 4.0 |
Gene Products, tat/*metabolism | 3 | 3.0 |
Positive Transcriptional Elongation Factor B | 2 | 3.0 |
Protein Kinases/*metabolism | 2 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 10 | 1.0 |
RNA Polymerase II/chemistry/*metabolism | 4 | 21.0 |
Base Sequence | 14 | 0.0 |
Carrier Proteins/genetics/metabolism | 2 | 1.0 |
Cloning, Molecular | 8 | 0.0 |
Comparative Study | 8 | 0.0 |
Protein Isoforms | 2 | 0.0 |
*Protein Kinases | 2 | 3.0 |
Sequence Alignment | 10 | 0.0 |
*Cyclin-Dependent Kinases | 25 | 13.0 |
*DNA Helicases | 2 | 0.0 |
*DNA-Binding Proteins | 3 | 0.0 |
Protein-Serine-Threonine Kinases/*genetics/metabolism | 2 | 3.0 |
*Transcription Factors, TFII | 16 | 15.0 |
Transcription, Genetic/*genetics | 2 | 1.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Cell Cycle/drug effects | 3 | 0.0 |
Cyclin-Dependent Kinases/*antagonists & inhibitors | 4 | 2.0 |
Cyclins/physiology | 3 | 7.0 |
Cell Cycle/*physiology | 4 | 1.0 |
Cyclin-Dependent Kinases/physiology | 2 | 7.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Tumor Cells, Cultured | 11 | 0.0 |
Enzyme Activation | 9 | 0.0 |
*Nuclear Proteins | 3 | 0.0 |
Serine/metabolism | 3 | 0.0 |
Spodoptera | 4 | 1.0 |
Models, Biological | 4 | 0.0 |
Transcription Factors/chemistry/genetics/*metabolism | 2 | 1.0 |
Purines/*pharmacology | 2 | 11.0 |
Species Specificity | 2 | 0.0 |
Substrate Specificity | 10 | 0.0 |
CDK9 Protein Kinase | 3 | 4.0 |
Cyclin-Dependent Kinases/genetics/*metabolism | 4 | 6.0 |
RNA Polymerase II/metabolism | 5 | 4.0 |
Transcription, Genetic | 9 | 0.0 |
Open Reading Frames | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Cell Division | 4 | 0.0 |
Cyclin B/metabolism | 2 | 2.0 |
Immunoblotting | 5 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 6 | 0.0 |
*Proto-Oncogene Proteins | 5 | 0.0 |
Ultraviolet Rays | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Adult | 3 | 0.0 |
Aged | 3 | 0.0 |
Cell Cycle | 5 | 0.0 |
Middle Aged | 4 | 0.0 |
Reference Values | 2 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Baculoviridae/genetics | 2 | 1.0 |
Mutation/genetics | 4 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Protein Kinases/metabolism | 4 | 0.0 |
Trans-Activators/metabolism | 2 | 0.0 |
Transcription Factors/metabolism | 4 | 0.0 |
DNA Repair/*genetics | 2 | 0.0 |
Heterozygote | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Cells, Cultured | 5 | 0.0 |
DNA Primers | 3 | 0.0 |
Binding Sites | 4 | 0.0 |
Alleles | 2 | 0.0 |
Blotting, Western | 7 | 0.0 |
Cell Nucleus/metabolism | 5 | 0.0 |
Cyclins/metabolism | 6 | 1.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Precipitin Tests | 4 | 0.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
COS Cells | 5 | 0.0 |
Estrogen Receptor alpha | 2 | 0.0 |
In Vitro | 2 | 0.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 2 | 0.0 |
Trans-Activation (Genetics) | 4 | 0.0 |
Chromatography, Gel | 2 | 0.0 |
G1 Phase | 2 | 0.0 |
*Tumor Suppressor Proteins | 2 | 0.0 |
RNA Polymerase II/*metabolism | 3 | 3.0 |
*Signal Transduction | 3 | 0.0 |
Transcription Factors/*metabolism | 5 | 0.0 |
Peptides/genetics/metabolism | 2 | 4.0 |
Mice | 7 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
Gene Expression Regulation, Neoplastic/drug effects | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
Mutation | 5 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Gene Expression | 2 | 0.0 |
Rats | 5 | 0.0 |
Down-Regulation | 2 | 0.0 |
DNA, Complementary | 3 | 0.0 |
Cell Division/*drug effects | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
G2 Phase/*drug effects | 2 | 6.0 |
Time Factors | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
cdc25 Phosphatase/metabolism | 2 | 3.0 |
Cell Cycle/*genetics | 2 | 2.0 |
Male | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Sequence Homology, Amino Acid | 8 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Transfection | 5 | 0.0 |
Cyclins/*metabolism | 7 | 2.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
Retinoblastoma Protein/metabolism | 2 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 2 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/metabolism | 2 | 1.0 |
Recombinant Proteins/genetics/metabolism | 2 | 0.0 |
Transcription Factors, TFII/*genetics/metabolism | 2 | 25.0 |
Macromolecular Substances | 6 | 0.0 |
Sequence Analysis | 2 | 0.0 |
*TATA-Binding Protein Associated Factors | 2 | 2.0 |
*Transcription Factor TFIID | 2 | 3.0 |
*Trans-Activation (Genetics) | 3 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Hamsters | 2 | 0.0 |
Protein-Serine-Threonine Kinases/*genetics | 3 | 1.0 |
DNA Repair | 4 | 0.0 |
Protein Conformation | 4 | 0.0 |
Protein-Serine-Threonine Kinases/chemistry/*metabolism | 2 | 5.0 |
Tissue Distribution | 2 | 0.0 |
Trans-Activators/*metabolism | 2 | 0.0 |
Antibodies | 2 | 0.0 |
Protein-Serine-Threonine Kinases/isolation & purification/*metabolism | 2 | 15.0 |
Recombinant Fusion Proteins/isolation & purification/metabolism | 2 | 2.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Cyclin-Dependent Kinases/*genetics | 2 | 3.0 |
Homozygote | 2 | 0.0 |
Female | 3 | 0.0 |
Clinical Trials | 2 | 0.0 |
Virus Replication/*drug effects | 2 | 1.0 |
Cyclin-Dependent Kinases/chemistry/genetics/*metabolism | 2 | 50.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Risk Factors | 3 | 0.0 |
Transcription, Genetic/physiology | 2 | 1.0 |
In Situ Hybridization | 2 | 0.0 |
RNA/metabolism | 2 | 0.0 |
